• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    INNOVATE Corp. Announces Closing of Rights Offering

    4/24/24 4:47:07 PM ET
    $VATE
    Metal Fabrications
    Industrials
    Get the next $VATE alert in real time by email

    NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), a diversified holding company, announced today the closing of its successful rights offering, which expired at 5:00 p.m., New York City time, on April 19, 2024. Pursuant to the terms of the rights offering, 5.2 million shares of common stock are being purchased pursuant to the exercise of basic subscription rights and 0.1 million additional shares of common stock are being purchased under the over-subscription privilege.

    In accordance with the Investment Agreement (the "Investment Agreement") entered into by the Company with Lancer Capital LLC ("Lancer Capital"), an investment fund led by Avram Glazer, the Chairman of the Board of Directors of the Company and the Company's largest stockholder, Lancer Capital partially backstopped the rights offering in the amount of $15.3 million by purchasing Series C Non-Voting Convertible Participating Preferred Stock, par value $0.001 per share (the "preferred stock"). In total, 15.3 thousand shares of preferred stock at a price of $1,000 per share were issued to Lancer Capital. This includes the approximately 6.3 thousand shares of preferred stock issued in connection with the closing of the rights offering and the 9.0 thousand shares already purchased as part of an equity advance arrangement under the Investment Agreement (the "equity advance"). On March 28, 2024, the Company issued and sold 25.0 thousand shares of the preferred stock to Lancer Capital for an aggregate purchase price of $25.0 million under the equity advance. The remaining 16.0 thousand shares of preferred stock purchased under the equity advance are part of the previously announced concurrent private placement. The preferred stock can be convertible into common stock at the price equivalent to the subscription price under the rights offering contingent on shareholder approval, which will be voted on at the next annual meeting.

    In the aggregate, the Company is issuing 5.3 million new shares of common stock at the subscription price of $0.70 per whole share for gross proceeds of $3.7 million to the Company, in addition to 31.3 thousand shares of preferred stock to Lancer Capital for gross proceeds of $31.3 million to the Company. After giving effect to the rights offering, the Company will have 85.2 million shares of common stock issued and outstanding. If approved at the annual meeting, the conversion of the 31.3 thousand shares of preferred stock purchased by Lancer Capital would result in the issuance of an additional 44.7 million shares of common stock.

    The Company expects to use the proceeds from the rights offering for general corporate purposes, including debt service and for working capital.

    Investors who have participated in the rights offering should expect to see the shares of common stock issued to them in uncertificated book-entry form. Any excess subscription payments received by Computershare Trust Company, N.A. (the "subscription agent") will be returned by the subscription agent to investors, without interest or deduction, through the same method by which they participated in the rights offering.

    The rights offering was made pursuant to INNOVATE's effective shelf registration statement on Form S-3, filed with the SEC on September 29, 2023 and declared effective on October 6, 2023, and a prospectus supplement containing the detailed terms of the rights offering filed with the SEC on March 8, 2024, as amended by that certain Amendment No. 1 to the prospectus supplement, filed with the SEC on March 25, 2024, and further amended by that certain Amendment No. 2 to the prospectus supplement, filed with the SEC on April 9, 2024.  This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities (including without limitation the preferred stock issued and sold in the concurrent private placement), nor shall there be any offer, solicitation or sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful under the securities laws of such state or jurisdiction. The rights offering was made only by means of a prospectus and a related prospectus supplement, copies of which were distributed to all eligible rights holders as of the rights offering record date and may also be obtained free of charge at the website maintained by the SEC at www.sec.gov or by contacting the information agent for the rights offering.

    About INNOVATE

    INNOVATE Corp. is a portfolio of best-in-class assets in three key areas of the new economy – Infrastructure, Life Sciences and Spectrum. Dedicated to stakeholder capitalism, INNOVATE employs approximately 4,000 people across its subsidiaries. For more information, please visit: www.INNOVATECorp.com.

    Cautionary Statement Regarding Forward-Looking Statements

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements regarding the rights offering and concurrent private placement, including, among others, statements related to the use of proceeds from the rights offering and other terms of the rights offering, all of which involve risks, assumptions and uncertainties, many of which are outside of the Company's control, and are subject to change. All forward-looking statements speak only as of the date made, and unless legally required, INNOVATE undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

    Contact:

    Solebury Strategic Communications

    Anthony Rozmus

    [email protected]

    (212) 235-2691



    Primary Logo

    Get the next $VATE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VATE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VATE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Transdermal GFR Article Recognized as One of Five 2025 Editors' Choice Articles by Journal of the American Society of Nephrology (JASN)

    MediBeacon® Transdermal GFR System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers began in January 2026 NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that MediBeacon Inc. ("MediBeacon"), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, in which INNOVATE owns a 44.7% equity interest, announced that the peer-reviewed transdermal GFR measurement article published in the Journal of the American Society of Nephrology (JASN) has been recognized as one of

    2/10/26 4:05:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend

    NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5 million, or $1.30 per share, on February 24, 2026 to DBMG's stockholders of record at the close of business on February 9, 2026. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $4.6 million of the total $5 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend. About INNOVATEINNOVATE Corp. is a portfoli

    2/2/26 8:30:00 AM ET
    $VATE
    Metal Fabrications
    Industrials

    DBM Global to Pay Cash Dividend

    PHOENIX, Jan. 30, 2026 (GLOBE NEWSWIRE) -- DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE:VATE), announced today that it will pay a cash dividend of approximately $5 million, or $1.30 per share, on February 24, 2026 to DBMG's stockholders of record at the close of business on February 9, 2026. About DBM Global Inc. DBMG is focused on delivering world class, sustainable value to its clients through a highly collaborative portfolio of companies which provide better designs, more efficient construction, and superior asset management solutions. The Company offers integrated steel cons

    1/30/26 4:05:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    SEC Filings

    View All

    INNOVATE Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - INNOVATE Corp. (0001006837) (Filer)

    2/10/26 4:08:31 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - INNOVATE Corp. (0001006837) (Filer)

    2/2/26 8:32:45 AM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - INNOVATE Corp. (0001006837) (Filer)

    12/16/25 8:07:05 AM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Director Glazer Avram A

    4/A - INNOVATE Corp. (0001006837) (Issuer)

    9/18/25 4:23:23 PM ET
    $VATE
    Metal Fabrications
    Industrials

    SEC Form 4 filed by Interim CEO Voigt Paul

    4 - INNOVATE Corp. (0001006837) (Issuer)

    9/17/25 4:37:51 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Interim CEO Voigt Paul was granted 176,056 shares, increasing direct ownership by 39% to 625,890 units (SEC Form 4)

    4 - INNOVATE Corp. (0001006837) (Issuer)

    8/7/25 4:37:47 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim CEO Voigt Paul bought $99,500 worth of shares (25,000 units at $3.98) (SEC Form 4)

    4 - INNOVATE Corp. (0001006837) (Issuer)

    11/21/24 4:49:08 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Interim CEO Voigt Paul bought $166,383 worth of shares (43,785 units at $3.80), increasing direct ownership by 26% to 211,655 units (SEC Form 4)

    4 - INNOVATE Corp. (0001006837) (Issuer)

    9/16/24 4:17:05 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Interim CEO Voigt Paul bought $106 worth of shares (176 units at $0.60), increasing direct ownership by 0.01% to 1,678,695 units (SEC Form 4)

    4 - INNOVATE Corp. (0001006837) (Issuer)

    6/17/24 4:36:10 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Financials

    Live finance-specific insights

    View All

    INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend

    NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5 million, or $1.30 per share, on February 24, 2026 to DBMG's stockholders of record at the close of business on February 9, 2026. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $4.6 million of the total $5 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend. About INNOVATEINNOVATE Corp. is a portfoli

    2/2/26 8:30:00 AM ET
    $VATE
    Metal Fabrications
    Industrials

    DBM Global to Pay Cash Dividend

    PHOENIX, Jan. 30, 2026 (GLOBE NEWSWIRE) -- DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE:VATE), announced today that it will pay a cash dividend of approximately $5 million, or $1.30 per share, on February 24, 2026 to DBMG's stockholders of record at the close of business on February 9, 2026. About DBM Global Inc. DBMG is focused on delivering world class, sustainable value to its clients through a highly collaborative portfolio of companies which provide better designs, more efficient construction, and superior asset management solutions. The Company offers integrated steel cons

    1/30/26 4:05:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE Corp. Announces Third Quarter 2025 Results

    - Infrastructure: DBM Global delivers robust revenue growth, reinforcing market leadership -- Life Sciences: MediBeacon received regulatory approval to sell the Transdermal GFR System in China -- Spectrum: New network launches underway; Fourth quarter advertising sales showing early signs of recovery - NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the third quarter.  Financial Summary (in millions, except per share amounts)Three Months Ended September 30, Nine Months Ended September 30,  2025   2024  Increase / (Decrease)  2025   2024  Increase / (Decrease)Revenue$347.1  $242.2  43.3% $86

    11/12/25 4:04:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Leadership Updates

    Live Leadership Updates

    View All

    MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

    MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this role, Dr. Miller will be focused on driving a range of clinical and strategic initiatives. Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and per

    5/16/23 7:00:00 AM ET
    $VATE
    Metal Fabrications
    Industrials

    Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary

    Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/

    2/13/23 8:00:00 AM ET
    $CTLT
    $PSEC
    $VATE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance

    INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors

    NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. "Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she will help guide us in our mission to drive shareholder value across our Infrastructure, Life Sciences and Spectrum operating segments," said Avie Glazer, Chairman of INNOVATE. "Amy's leadership and strategy consulting experience advising Fortune 500 companies will be a valuable addition to our Board," said Wayne Barr, Jr., Chief Executive Officer of INNOVATE

    8/2/22 4:15:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by INNOVATE Corp.

    SC 13G/A - INNOVATE Corp. (0001006837) (Subject)

    11/13/24 9:30:32 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13D/A filed by INNOVATE Corp.

    SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

    6/21/24 7:05:53 PM ET
    $VATE
    Metal Fabrications
    Industrials

    SEC Form SC 13D/A filed by INNOVATE Corp. (Amendment)

    SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

    4/1/24 4:18:15 PM ET
    $VATE
    Metal Fabrications
    Industrials